Citi Upgrades Illumina, Quest, Agilent to Buy, Downgrades Avantor
10x Genomics Stock Slides 14% Amid Illumina Deal, Deutsche Downgrade
Stephens & Co. Reiterates Overweight on Illumina, Maintains $170 Price Target
Illumina Analyst Ratings
Illumina Analyst Ratings
Illumina Analyst Ratings
Evercore ISI Cuts Price Target on Illumina to $175 From $195
Illumina Analyst Ratings
TD Cowen Adjusts Price Target on Illumina to $122 From $140
Nephron Research Upgrades Illumina to Hold, Price Target at $100
Illumina Analyst Ratings
Daiwa Securities Adjusts Price Target on Illumina to $120 From $133
TD Cowen Sticks to Its Hold Rating for Illumina (ILMN)
Illumina Analyst Ratings
Scotiabank Maintains Sector Outperform on Illumina, Lowers Price Target to $176
Leerink Adjusts Price Target on Illumina to $150 From $155
Illumina Analyst Ratings
Leerink Partners Adjusts Illumina's Price Target to $155 From $170
Stephens Sticks to Their Buy Rating for Illumina (ILMN)
Illumina Analyst Ratings